Pfizer Stock Falls to New 52-Week Low: Should You Buy the Dip?
Pfizer’s (PFE) stock hit a new 52-week low of 22.49Though the stock has seen ups and downs in the past year, the latest price decline is largely due to the global uncertainty caused by the tariff war. With the Trump administration imposing sweeping tariffs, fears of a global recession resulted in a stock market rout worldwide. Though pharmaceuticals have been exempted from tariffs this time around, they could well be Trump’s target in the next roun ...